Polyclonal Rabbit anti‑Human NME3 Antibody (APC,Cy7, aa1‑168, WB) LS‑C737289
Polyclonal Rabbit anti‑Human NME3 Antibody (APC,Cy7, aa1‑168, WB) LS‑C737289
Antibody:
NME3 Rabbit anti-Human Polyclonal (aa1-168) (APC, Cy7) Antibody
Reactivity:
Human, Mouse, Pig
Format:
Allophycocyanin, Cy7, Unmodified
Overview
Antibody:
NME3 Rabbit anti-Human Polyclonal (aa1-168) (APC, Cy7) Antibody
Reactivity:
Human, Mouse, Pig
Format:
Allophycocyanin, Cy7, Unmodified
Specifications
Description
NME3 antibody LS-C737289 is an APC, Cy7-conjugated rabbit polyclonal antibody to NME3 (aa1-168) from human. It is reactive with human, mouse and pig. Validated for WB.
Target
Human NME3
Synonyms
NME3 | DR-nm23 | NDP kinase 3 | NDK 3 | NDPKC | NM23-H3 | NM23H3 | NDP kinase C | NDPK-C | C371H6.2
Reactivity
Human, Mouse, Pig
(tested or 100% immunogen sequence identity)
Conjugations
Allophycocyanin, Cy7.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
Cy3,
HRP,
APC,
PE.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant NME3 (Met1-Tyr168) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against NME3.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot, ELISA
Reactivity:
Mouse
Range:
0.625-40 ng/ml
Species:
Mouse
Applications:
Western blot
Reactivity:
Range:
123.5-10000 ng/ml
Reactivity:
Porcine
Range:
0.31-20 ng/ml
Reactivity:
Human
Range:
7.8-500 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/28/2024